BioSpace News Archive

Syngenta and the Analytics Society of INFORMS are proud to recognize a team from The International Center for Tropical Agriculture (CIAT) in Colombia as the winner of the 2018 Syngenta Crop Challenge in Analytics.

Softheon announced today its private-label enrollment solution, which provides Enhanced Direct Enrollment-as-a-service (EDE).

Visikol Inc., established with an investment from Foundation Venture Capital Group (FVCG), an affiliate of New Jersey Health Foundation (NJHF), has secured a new round of funding led by industry executives, announced James M. Golubieski, president of FVCG.

ReviveMed Inc. announced it has closed an oversubscribed seed round of $1.5 million to advance its artificial intelligence (AI)-driven platform that unlocks the value of metabolomics data for drug discovery and development.

Dr. Bryan Gawley, MD, has been announced as one of PHEONIX Magazine’s Top Doctors of 2018.

The Pharmaceutical Care Management Association (PCMA) will hold its annual “PBM Policy Forum” tomorrow, April 19, at the Newseum in Washington, D.C.

eurocrine Biosciences, Inc. announced that new data for once-daily INGREZZA® (valbenazine) capsules, the first U.S. Food and Drug Administration (FDA) approved treatment for adults with tardive dyskinesia (TD), will be presented at the American Academy of Neurology (AAN) Annual Meeting in Los Angeles, Calif., April 21-27, 2018.

Milestone achieved under the highly successful strategic alliance Evotec and Bayer entered in October 2012.

Orphan drug designation will give the KL1333 program extra access to regulatory and scientific advice and interactions at the FDA

The Medicare Set-Aside program of the Centers for Medicare and Medicaid Services “encourages, intensifies and effectively orders long-term opioid use and abuse by Medicare beneficiaries,” according to the National Alliance of Medicare Set-Aside Professionals.